FOLH1 and prostate cancer: This suggests that PSMA is capable of activating the PI3K-Akt cell survival pathway in prostate cancer and surprisingly finds mGluRI as the major mediator of folate-induced PI3Kβ-Akt pathway activation by PSMA.